{
  "CellLine_hpscreg_id": "AIBNi009-A",
  "CellLine_alt_names": [
    "GENIE 49"
  ],
  "CellLine_cell_line_type": "hiPSC",
  "CellLine_source_cell_type": "Peripheral blood mononuclear cells",
  "CellLine_publication_doi": "10.1016/j.scr.2022.102673",
  "CellLine_publication_pmid": "",
  "CellLine_publication_title": "Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening",
  "CellLine_publication_first_author": "Zoe L. Hunter",
  "CellLine_publication_last_author": "Lata Vadlamudi",
  "CellLine_publication_journal": "Stem Cell Research",
  "CellLine_publication_year": 2022,
  "CellLine_donor_age": 29,
  "CellLine_donor_sex": "Female",
  "CellLine_donor_disease_name": "Epilepsy",
  "CellLine_donor_disease_description": "A neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain.",
  "CellLine_source_tissue": "Blood",
  "CellLine_source": "donor",
  "CellLine_contact_name": "Professor Ernst J Wolvetang",
  "CellLine_contact_email": "e.wolvetang@uq.edu.au",
  "CellLine_contact_phone": "",
  "CellLine_maintainer": "Australian Institute for Bioengineering and Nanotechnology",
  "CellLine_producer": "Australian Institute for Bioengineering and Nanotechnology",
  "CellLine_frozen": true,
  "GenomicAlteration_mutation_type": "transgene expression",
  "GenomicAlteration_cytoband": "",
  "GenomicAlteration_delivery_method": "non-integrated",
  "GenomicAlteration_loci_name": "",
  "GenomicAlteration_loci_start": 0,
  "GenomicAlteration_loci_end": 0,
  "GenomicAlteration_loci_group": "",
  "GenomicAlteration_loci_disease": "",
  "GenomicAlteration_description": "Non-integrative Sendai virus delivery of OCT4, SOX2, KLF4 and c-MYC transgenes",
  "GenomicAlteration_genotype": "",
  "GenomicAlteration_performed": true,
  "PluripotencyCharacterisation_cell_type": "Endoderm",
  "PluripotencyCharacterisation_shown_potency": true,
  "PluripotencyCharacterisation_marker_list": [
    "OCT4",
    "SOX2",
    "NANOG",
    "TRA-1-60",
    "TRA-1-81"
  ],
  "PluripotencyCharacterisation_method": "Immunocytochemistry and qPCR",
  "PluripotencyCharacterisation_differentiation_profile": "in vitro directed differentiation",
  "ReprogrammingMethod_vector_type": "non-integrated",
  "ReprogrammingMethod_vector_name": "Sendai virus",
  "ReprogrammingMethod_kit": "CytoTune-iPS 2.0 Sendai Reprogramming Kit",
  "ReprogrammingMethod_detected": true,
  "GenomicCharacterisation_passage_number": 15,
  "GenomicCharacterisation_karyotype": "46, XX",
  "GenomicCharacterisation_karyotype_method": "G-Banding",
  "GenomicCharacterisation_summary": "Karyotype analysis revealed a normal female karyotype (46XX) without G-banding abnormalities.",
  "STR_Results_exists": true,
  "STR_Results_loci": 10,
  "STR_Results_group": "Non-HLA",
  "STR_Results_allele_1": "",
  "STR_Results_allele_2": "",
  "InducedDerivation_i_source_cell_type": "Peripheral blood mononuclear cells",
  "InducedDerivation_i_cell_origin": "Blood",
  "InducedDerivation_derivation_year": "2020",
  "InducedDerivation_vector_type": "non-integrated",
  "InducedDerivation_vector_name": "Sendai virus",
  "InducedDerivation_kit_name": "CytoTune-iPS 2.0 Sendai Reprogramming Kit",
  "Ethics": [
    {
      "ethics_number": "2019/QRBW/54086",
      "approval_date": "",
      "institution": "Royal Brisbane and Women's Hospital Human Research Ethics Committee"
    },
    {
      "ethics_number": "2019002273",
      "approval_date": "",
      "institution": "The University of Queensland Human Ethics Research Office"
    }
  ],
  "MicrobiologyVirologyScreening_performed": true,
  "MicrobiologyVirologyScreening_hiv1": "",
  "MicrobiologyVirologyScreening_hiv2": "",
  "MicrobiologyVirologyScreening_hep_b": "",
  "MicrobiologyVirologyScreening_hep_c": "",
  "MicrobiologyVirologyScreening_mycoplasma": "Negative",
  "MicrobiologyVirologyScreening_other": "",
  "MicrobiologyVirologyScreening_other_result": "",
  "CultureMedium_co2_concentration": 5,
  "CultureMedium_o2_concentration": 21,
  "CultureMedium_passage_method": "Enzyme-free cell dissociation",
  "CultureMedium_base_medium": "mTeSR Plus",
  "CultureMedium_base_coat": "Matrigel"
}